U.S. Auto Components Stock News

NYSE:NNI
NYSE:NNIConsumer Finance

Nelnet (NNI) Margin Strength In FY 2025 Challenges Cautious Community Narratives

How Nelnet's FY 2025 Numbers Landed Nelnet (NNI) has wrapped up FY 2025 with fourth quarter revenue of US$348.3 million and basic EPS of US$1.60, anchored by net income of US$57.8 million as investors weigh that against a trailing twelve month EPS of US$11.79 on US$1.68 billion of revenue. Over the past two reported years in this data set, quarterly revenue has ranged from US$289.7 million in Q3 2024 to US$516.1 million in Q2 2025, while basic EPS has moved between US$0.07 and US$4.97. This...
NasdaqGS:DHIL
NasdaqGS:DHILCapital Markets

Diamond Hill Investment Group (DHIL) Margin Expansion Challenges Bearish Earnings Narratives

Diamond Hill Investment Group (DHIL) closed out FY 2025 with Q4 revenue of US$36.6 million and basic EPS of US$3.43, while trailing 12 month figures stood at US$147.1 million of revenue and EPS of US$17.91, underpinned by 12.9% earnings growth over the last year. The company has seen revenue move from US$151.1 million and EPS of US$15.66 on a trailing basis in FY 2024 to the latest US$147.1 million and US$17.91, alongside net income of US$48.8 million over the same trailing period. With net...
NasdaqGS:BIDU
NasdaqGS:BIDUInteractive Media and Services

Assessing Baidu (NasdaqGS:BIDU) Valuation After Recent Share Price Weakness And Strong 1-Year Return

Recent performance snapshot Baidu (NasdaqGS:BIDU) has drawn investor attention after a one-month return of about a 21% decline, alongside a roughly 6% gain over the past three months and a 1-year total return of about 44%. See our latest analysis for Baidu. At a share price of US$124.42, Baidu’s recent 21% one month share price decline and softer 7 day performance suggest momentum has cooled, even though the 1 year total shareholder return of about 44% remains much stronger than its longer...
NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

MannKind (MNKD) Margin Compression To 1.7% TTM Net Margin Fuels Bearish Narratives

MannKind (MNKD) has wrapped up FY 2025 with fourth quarter revenue of US$112 million and a basic EPS loss of US$0.05, setting a clear focal point for investors watching how its income statement is evolving. Over recent periods the company has seen revenue move from US$70 million in Q3 2024 to US$82 million in Q3 2025, while quarterly EPS has ranged from US$0.04 in Q1 2025 to a small profit of US$0.03 in Q3 2025 before this latest loss. This puts the spotlight firmly on how durable its margins...
NYSE:HRB
NYSE:HRBConsumer Services

Shorter Tax Window Puts H&R Block’s Small Business Expertise In Focus

New legislation reduces the required holding period for certain small business stock investments from five years to three years for partial capital gains tax relief. H&R Block (NYSE:HRB) is providing expert commentary through its Small Business Tax Director on what the shorter holding period could mean for investors and entrepreneurs. The changes are expected to influence tax planning decisions for small business owners and investors evaluating long term equity stakes. H&R Block, known...
NasdaqGS:TROW
NasdaqGS:TROWCapital Markets

Is T. Rowe Price (TROW) Attractive After Recent Share Price Weakness?

If you are wondering whether T. Rowe Price Group shares offer fair value at around US$94.63, this article walks through what the numbers suggest and how to think about the price you are paying. The stock has seen a 0.8% decline over the last week, a 10.1% decline over the last month, a 9.6% decline year to date, and a 5.7% decline over the last year. The 3 year and 5 year returns stand at a 4.0% decline and a 31.8% decline respectively. Recent market attention on asset managers has focused...
NasdaqGS:OPK
NasdaqGS:OPKHealthcare

OPKO Health (OPK) Loss Worsens To US$0.30 TTM EPS Challenging Turnaround Narratives

OPKO Health (OPK) just closed out FY 2025 with Q4 revenue of US$148.45 million, basic EPS of a US$0.04 loss, and quarterly net income excluding extra items showing a loss of US$31.26 million, set against trailing twelve month revenue of US$606.88 million and a loss of US$225.68 million on the same basis. The company has seen quarterly revenue move from US$183.64 million and basic EPS of US$0.02 in Q4 2024 to US$148.45 million and basic EPS of a US$0.04 loss in Q4 2025, while trailing twelve...
NYSE:ALEX
NYSE:ALEXREITs

Alexander & Baldwin (ALEX) Q4 FFO Loss Challenges Bullish Hawaii REIT Narratives

Alexander & Baldwin (ALEX) has wrapped up FY 2025 with fourth quarter revenue of US$43.8 million and basic EPS of US$0.05, alongside trailing twelve month revenue of US$206.7 million and EPS of US$0.89. Over the last six quarters, the company has seen quarterly revenue move from US$63.2 million in Q4 2024 to US$56.8 million in Q1 2025 and down to US$43.8 million in Q4 2025, while quarterly EPS moved from US$0.18 to US$0.29 and then US$0.05. This sets up a mixed backdrop for a stock trading at...
NasdaqGS:OPEN
NasdaqGS:OPENReal Estate

Opendoor Turnaround Shows AI Progress But Valuation And Losses Raise Questions

Opendoor Technologies (NasdaqGS:OPEN) is reporting progress on its turnaround, with faster inventory turns, more home acquisitions, and early benefits from AI tools. The company recently highlighted a 46% increase in home acquisitions, better resale velocity, and tighter inventory management despite a tough housing market. Management is also rolling out an AI driven operating model and a beta mortgage product as it leans into an e commerce style platform for residential real estate. For...
NasdaqGM:CAMT
NasdaqGM:CAMTSemiconductor

Why Camtek (CAMT) Is Up 13.0% After Issuing Bullish 2026 Outlook On AI-Focused Growth

In February 2026, Camtek Ltd. reported its fourth‑quarter 2025 results, with sales rising to US$128.12 million and net income to US$35.9 million, alongside higher quarterly earnings per share than a year earlier. Despite full‑year 2025 net income dropping to US$50.72 million even as sales grew to US$496.07 million, management issued upbeat 2026 guidance, highlighting expected double‑digit revenue growth supported by a solid backlog and customer pipeline. We’ll now examine how Camtek’s...
NasdaqGS:HOOD
NasdaqGS:HOODCapital Markets

Robinhood Chain And New Fund Expand Access While Valuation Signals Caution

Robinhood Markets (NasdaqGS:HOOD) has launched Robinhood Chain, its own blockchain designed to support expanded crypto trading and tokenized assets. The company has also introduced Robinhood Ventures Fund I, a new vehicle aimed at giving retail investors access to private company investments. Both offerings are being rolled out as part of a broader push to widen Robinhood's product set for individual investors. Robinhood, best known for its zero commission stock and crypto trading app, is...
NasdaqGS:OKTA
NasdaqGS:OKTAIT

Okta Security Leadership Award Draws Attention To Valuation And Growth Story

Okta's SVP & CTO Steve Williams received the Leadership ORBIE Award at the 2026 DallasCISO ORBIE Awards. The award recognizes Williams for leadership and impact on enterprise security. The recognition spotlights Okta's role in identity and access management and enterprise security transformation. For investors watching NasdaqGS:OKTA, this recognition comes as identity and access management remains an area of focus for organizations that prioritize secure user access and authentication...
NasdaqGS:APLD
NasdaqGS:APLDIT

Applied Digital Faces CoreWeave Dependence And Contract Risks For Future Revenue

Applied Digital (NasdaqGS:APLD) faces material risk from heavy reliance on a single major tenant, CoreWeave, for a substantial share of its future revenue. CoreWeave is currently unprofitable and highly leveraged, which raises concerns about its long term ability to meet multi year commitments. Many of Applied Digital’s leases include termination clauses that allow tenants to walk away without penalty if construction milestones are not met. The company has taken on a large amount of debt...
NasdaqGM:ZLAB
NasdaqGM:ZLABBiotechs

Zai Lab (NasdaqGM:ZLAB) Loss Per Share Narrows To US$1.60 And Tests Bearish Narratives

Zai Lab (NasdaqGM:ZLAB) closed out FY 2025 with fourth quarter revenue of US$127.6 million and a basic EPS loss of US$0.46. Trailing 12 month figures show revenue of US$460.2 million and a basic EPS loss of US$1.60. Over recent periods the company has seen revenue range from US$102.3 million in Q3 2024 to US$127.6 million in Q4 2025, with quarterly basic EPS losses moving between US$0.33 and US$0.80. This sets up a picture where scale is building but margins are still under pressure for...
NasdaqGS:TPG
NasdaqGS:TPGCapital Markets

A Look At TPG (TPG) Valuation After Concerns Over Market Financial Solutions Exposure

TPG (TPG) stock has come under pressure after investors focused on its £44 million exposure to failed UK mortgage lender Market Financial Solutions, which faces a reported £930 million collateral shortfall. See our latest analysis for TPG. The £44 million exposure to Market Financial Solutions comes on top of other recent headlines for TPG, including its role in a US$450 million Xerox joint venture financing and interest in the MarineMax sale process. Despite those developments, the share...
NYSE:ALTG
NYSE:ALTGTrade Distributors

Alta Equipment Group Q4 Losses Deepen Concerns Around Bullish Margin Narratives

Alta Equipment Group (ALTG) has reported fourth quarter FY 2025 revenue of US$509.1 million with a basic EPS loss of US$0.39, setting the tone for a year where the business stayed focused on scale while earnings remained in the red. The company has seen quarterly revenue move from US$448.8 million in Q3 2024 to US$498.1 million in Q4 2024, then to US$423.0 million in Q1 2025 and up to US$509.1 million in Q4 2025, while basic EPS over that stretch ranged from a loss of US$0.34 to a loss of...
NasdaqCM:WULF
NasdaqCM:WULFSoftware

TeraWulf (WULF) TTM Loss Of US$661 Million Tests Bullish Margin Improvement Narrative

TeraWulf (WULF) closed FY 2025 with Q4 revenue of US$35.8 million and a basic EPS loss of US$0.30, alongside a trailing twelve month revenue base of US$168.5 million and a full year EPS loss of US$1.66. Over the last six reported quarters, revenue has ranged from US$27.1 million in Q3 2024 to US$50.6 million in Q3 2025, while quarterly basic EPS losses have moved between US$0.05 and US$1.13. This gives investors a clear picture of a business still working through heavy losses. With trailing...
NYSE:MTG
NYSE:MTGDiversified Financial

A Look At MGIC Investment (MTG) Valuation After Recent Share Price Consolidation

Why MGIC Investment (MTG) Is On Investors’ Radar Today MGIC Investment (MTG) is drawing attention after recent trading left the mortgage insurer’s shares roughly flat over the past month, with a modest loss over the past 3 months and a decline year to date. See our latest analysis for MGIC Investment. At a share price of US$26.53, MGIC Investment’s short term share price return over the past 90 days has been negative, while its 1 year and 5 year total shareholder returns remain firmly...
NYSE:HPP
NYSE:HPPOffice REITs

Hudson Pacific Properties (HPP) FFO Hovering Near Breakeven Challenges Bearish Narratives

Hudson Pacific Properties (HPP) closed out FY 2025 with Q4 revenue of US$256.0 million and basic EPS of US$4.31 loss, while trailing twelve month revenue came in at US$831.1 million alongside a TTM basic EPS of US$12.81 loss. This gives investors a clear snapshot of pressure on per share results. Over recent periods, the company has seen quarterly revenue shift from US$208.8 million in Q4 2024 to US$256.0 million in Q4 2025, with basic EPS moving from a loss of US$8.28 per share to a loss of...
NYSE:DK
NYSE:DKOil and Gas

Delek US Holdings (DK) Posts Q4 Profit While TTM Loss Keeps Bearish Narrative Intact

Delek US Holdings (DK) closed out FY 2025 with Q4 revenue of US$2,429.4 million and basic EPS of US$1.32, alongside net income from continuing operations of US$79.5 million. Over the past few quarters, revenue has moved between US$2,641.9 million and US$2,887 million while basic EPS has swung from a loss of US$2.78 in Q1 2025 to a profit of US$2.96 in Q3 2025 and then US$1.32 in Q4, highlighting the sensitivity of margins to refining conditions and product mix. See our full analysis for Delek...
NasdaqGS:CCCC
NasdaqGS:CCCCBiotechs

C4 Therapeutics (CCCC) Quarterly Loss Narrows To US$20.5m Challenging Persistent Bearish Narratives

C4 Therapeutics (CCCC) just posted its FY 2025 Q4 numbers, with revenue of US$11.0 million and a quarterly loss translating to basic EPS of US$0.18, set against a trailing twelve month loss of US$105.0 million and EPS of US$1.27 on revenue of US$35.9 million. Over recent quarters, the company has seen revenue move between US$5.2 million and US$15.4 million, while quarterly EPS has ranged from US$0.35 to US$0.49 and quarterly losses from US$24.7 million to US$34.6 million. The key question for...
NYSE:CI
NYSE:CIHealthcare

Cigna Group (CI) Margin Improvement To 2.2% Challenges Skeptical Earnings Narratives

Cigna Group (CI) has wrapped up FY 2025 with fourth quarter revenue of US$72.5b, basic EPS of US$4.67 and net income of US$1,234m, putting a clear spotlight on how the year’s strong headline numbers translate into underlying profitability. The company has seen quarterly revenue move from US$65.6b in Q4 2024 to US$72.5b in Q4 2025, with basic EPS shifting from US$5.13 to US$4.67 over the same period. Trailing 12 month EPS reached US$22.33 on net income of US$5,957m, highlighting a year in...
NasdaqGM:GDEN
NasdaqGM:GDENHospitality

Golden Entertainment (GDEN) Loss Deepens In Q4 EPS Miss Challenges Profit-Recovery Narrative

Golden Entertainment (GDEN) has wrapped up FY 2025 with Q4 revenue of US$155.6 million and a basic EPS loss of US$0.33, alongside net income excluding extra items of a US$8.5 million loss. Over recent periods, the company has seen quarterly revenue move between US$154.8 million and US$164.2 million, while EPS has swung from a profit of US$0.18 in Q3 2024 to a loss of US$0.33 in Q4 2025. This leaves investors watching how quickly margins can stabilize from here. See our full analysis for...
NasdaqGM:CSTL
NasdaqGM:CSTLHealthcare

Castle Biosciences (CSTL) Q4 EPS Loss Tests Bullish Profitability Narrative

Castle Biosciences (CSTL) has wrapped up FY 2025 with Q4 revenue of US$87 million and a basic EPS loss of US$0.08, alongside trailing twelve month revenue of US$344.2 million and a basic EPS loss of US$0.83. Over recent periods, the company has seen quarterly revenue range from US$83 million to US$88 million, while basic EPS has moved between a loss of US$0.90 and a profit of US$0.16. This sets the stage for investors to focus closely on how those revenue levels translate into sustainable...